• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷 Rg3 的抗血管生成特性。

Anti-Angiogenic Properties of Ginsenoside Rg3.

机构信息

Molecular Oncology, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia.

Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia.

出版信息

Molecules. 2020 Oct 23;25(21):4905. doi: 10.3390/molecules25214905.

DOI:10.3390/molecules25214905
PMID:33113992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7660320/
Abstract

Ginsenoside Rg3 (Rg3) is a member of the ginsenoside family of chemicals extracted from . Like other ginsenosides, Rg3 has two epimers: 20(S)-ginsenoside Rg3 (SRg3) and 20(R)-ginsenoside Rg3 (RRg3). Rg3 is an intriguing molecule due to its anti-cancer properties. One facet of the anti-cancer properties of Rg3 is the anti-angiogenic action. This review describes the controversies on the effects and effective dose range of Rg3, summarizes the evidence on the efficacy of Rg3 on angiogenesis, and raises the possibility that Rg3 is a prodrug.

摘要

人参皂苷 Rg3(Rg3)是从 中提取的人参皂苷类化学物质的一员。与其他人参皂苷一样,Rg3 有两个差向异构体:20(S)-人参皂苷 Rg3(SRg3)和 20(R)-人参皂苷 Rg3(RRg3)。由于其抗癌特性,Rg3 是一种有趣的分子。Rg3 的抗癌特性之一是抗血管生成作用。本综述描述了关于 Rg3 的作用和有效剂量范围的争议,总结了 Rg3 对血管生成作用的疗效证据,并提出了 Rg3 可能是前药的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/496c/7660320/009efc8f5b0b/molecules-25-04905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/496c/7660320/ca9aa711b06d/molecules-25-04905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/496c/7660320/009efc8f5b0b/molecules-25-04905-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/496c/7660320/ca9aa711b06d/molecules-25-04905-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/496c/7660320/009efc8f5b0b/molecules-25-04905-g002.jpg

相似文献

1
Anti-Angiogenic Properties of Ginsenoside Rg3.人参皂苷 Rg3 的抗血管生成特性。
Molecules. 2020 Oct 23;25(21):4905. doi: 10.3390/molecules25214905.
2
The angiosuppressive effects of 20(R)- ginsenoside Rg3.20(R)-人参皂苷Rg3的血管抑制作用。
Biochem Pharmacol. 2006 Aug 14;72(4):437-45. doi: 10.1016/j.bcp.2006.04.034. Epub 2006 May 12.
3
Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.人参皂苷 Rg3 通过抑制内皮祖细胞的生物活性来抑制肿瘤血管生成。
Cancer Biol Ther. 2012 May;13(7):504-15. doi: 10.4161/cbt.19599. Epub 2012 May 1.
4
20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK.20(S)-人参皂苷Rg3增强葡萄糖刺激的胰岛素分泌并激活AMPK。
Biol Pharm Bull. 2008 Apr;31(4):748-51. doi: 10.1248/bpb.31.748.
5
Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models.人参皂苷Rg3对三阴性乳腺癌细胞模型的立体选择性抗癌活性
Pharmaceuticals (Basel). 2019 Aug 1;12(3):117. doi: 10.3390/ph12030117.
6
Ginsenoside-Rb2 and 20(S)-Ginsenoside-Rg3 from Korean Red Ginseng Prevent Rotavirus Infection in Newborn Mice.朝鲜红参中的人参皂苷 - Rb2和20(S)-人参皂苷 - Rg3可预防新生小鼠感染轮状病毒。
J Microbiol Biotechnol. 2018 Mar 28;28(3):391-396. doi: 10.4014/jmb.1801.01006.
7
Stereospecificity of ginsenoside Rg3 action on ion channels.人参皂苷Rg3对离子通道作用的立体特异性。
Mol Cells. 2004 Dec 31;18(3):383-9.
8
Biotransformation of ginsenoside Rb1 to ginsenoside Rg3 by endophytic bacterium Burkholderia sp. GE 17-7 isolated from Panax ginseng.从人参中分离出的内生细菌伯克霍尔德氏菌属GE 17-7将人参皂苷Rb1生物转化为人参皂苷Rg3 。
J Appl Microbiol. 2017 Jun;122(6):1579-1585. doi: 10.1111/jam.13435. Epub 2017 May 3.
9
Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.人参皂苷20-Rg3的立体特异性作用抑制TGF-β1诱导的上皮-间质转化并抑制肺癌的迁移、侵袭和失巢凋亡抗性。
Toxicology. 2014 Aug 1;322:23-33. doi: 10.1016/j.tox.2014.04.002. Epub 2014 May 2.
10
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments.人参皂苷Rg3差向异构体的抗血管生成特性:单药及联合治疗的体外评估
Cancers (Basel). 2021 May 6;13(9):2223. doi: 10.3390/cancers13092223.

引用本文的文献

1
Molecular mechanisms underlying the inhibition of cell migration and invasion in endometriosis: Advances in pharmacological research (Review).子宫内膜异位症中细胞迁移和侵袭抑制的分子机制:药理学研究进展(综述)
Biomed Rep. 2025 Jul 8;23(3):152. doi: 10.3892/br.2025.2030. eCollection 2025 Sep.
2
RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration.用于减轻年龄相关性黄斑变性中氧化应激和脉络膜新生血管的RGD功能化人参皂苷Rg3脂质体
Int J Nanomedicine. 2025 Jun 19;20:7915-7933. doi: 10.2147/IJN.S520756. eCollection 2025.
3

本文引用的文献

1
Acute and repeated dose 26-week oral toxicity study of 20(S)-ginsenoside Rg3 in Kunming mice and Sprague-Dawley rats.20(S)-人参皂苷Rg3对昆明小鼠和Sprague-Dawley大鼠的急性及重复给药26周经口毒性研究
J Ginseng Res. 2020 Mar;44(2):222-228. doi: 10.1016/j.jgr.2018.10.001. Epub 2018 Oct 19.
2
A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs.20(S)-人参皂甙 Rg3 在比格犬中口服 26 周的毒性研究。
Regul Toxicol Pharmacol. 2020 Feb;110:104522. doi: 10.1016/j.yrtph.2019.104522. Epub 2019 Nov 11.
3
Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis.
Natural anti-cancer products: insights from herbal medicine.
天然抗癌产品:来自草药医学的见解。
Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y.
4
Harnessing Jasmonate Pathways: PgJAR1's Impact on Ginsenoside Accumulation in Ginseng.利用茉莉酸途径:PgJAR1对人参中人参皂苷积累的影响
Plants (Basel). 2025 Mar 8;14(6):847. doi: 10.3390/plants14060847.
5
An alternative way to break the matrix barrier: an experimental study of a LIFU-mediated, visualizable targeted nanoparticle synergistic amplification for the treatment of malignant fibroblasts.突破基质屏障的另一种方法:聚焦超声介导的可视化靶向纳米颗粒协同扩增治疗恶性成纤维细胞的实验研究
Front Bioeng Biotechnol. 2024 Nov 5;12:1486369. doi: 10.3389/fbioe.2024.1486369. eCollection 2024.
6
Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review.人参皂苷作为辅助治疗肝细胞癌的疗效、安全性和临床结局的评价:荟萃分析和系统评价。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241293790. doi: 10.1177/15347354241293790.
7
Ginsenoside Rg3 activates the immune function of CD8+ T cells via circFOXP1-miR-4477a-PD-L1 axis to induce ferroptosis in gallbladder cancer.人参皂苷Rg3通过circFOXP1-miR-4477a-PD-L1轴激活CD8+ T细胞的免疫功能,从而诱导胆囊癌发生铁死亡。
Arch Pharm Res. 2024 Nov;47(10-11):793-811. doi: 10.1007/s12272-024-01516-y. Epub 2024 Oct 28.
8
Ginsenoside Rg3 attenuates myocardial ischemia/reperfusion-induced ferroptosis via the keap1/Nrf2/GPX4 signaling pathway.人参皂苷 Rg3 通过 Keap1/Nrf2/GPX4 信号通路减轻心肌缺血/再灌注诱导的铁死亡。
BMC Complement Med Ther. 2024 Jun 26;24(1):247. doi: 10.1186/s12906-024-04492-4.
9
Ginsenoside Rg3 induces mesangial cells proliferation and attenuates apoptosis by miR-216a-5p/MAPK pathway in diabetic kidney disease.人参皂苷 Rg3 通过 miR-216a-5p/MAPK 通路诱导系膜细胞增殖并减轻糖尿病肾病中的细胞凋亡。
Aging (Albany NY). 2024 Jun 7;16(11):9933-9943. doi: 10.18632/aging.205907.
10
Biosynthesis and functions of triterpenoids in cereals.谷物中三萜类化合物的生物合成与功能
J Adv Res. 2025 May;71:155-171. doi: 10.1016/j.jare.2024.05.021. Epub 2024 May 23.
人参皂苷 Rg3 通过诱导细胞凋亡和抑制血管生成延长原位肝癌模型的生存期。
Anal Cell Pathol (Amst). 2019 Aug 26;2019:3815786. doi: 10.1155/2019/3815786. eCollection 2019.
4
Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway.原人参二醇通过靶向 STAT3 通路抑制肝癌上皮间质转化。
Cell Death Dis. 2019 Aug 20;10(9):630. doi: 10.1038/s41419-019-1733-8.
5
Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models.人参皂苷Rg3对三阴性乳腺癌细胞模型的立体选择性抗癌活性
Pharmaceuticals (Basel). 2019 Aug 1;12(3):117. doi: 10.3390/ph12030117.
6
Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia mir-491.人参皂苷 Rh2 抑制低氧下肺癌细胞的迁移 mir-491。
Anticancer Agents Med Chem. 2019;19(13):1633-1641. doi: 10.2174/1871520619666190704165205.
7
Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways.人参皂苷 Rg3 通过下调 ERK 和 Akt 通路对黑色素瘤的抗肿瘤活性。
Int J Oncol. 2019 Jun;54(6):2069-2079. doi: 10.3892/ijo.2019.4787. Epub 2019 Apr 16.
8
Bumetanide-Derived Aquaporin 1 Inhibitors, AqB013 and AqB050 Inhibit Tube Formation of Endothelial Cells through Induction of Apoptosis and Impaired Migration In Vitro.布美他尼衍生水通道蛋白 1 抑制剂 AqB013 和 AqB050 通过诱导细胞凋亡和体外迁移受损抑制血管内皮细胞管腔形成。
Int J Mol Sci. 2019 Apr 12;20(8):1818. doi: 10.3390/ijms20081818.
9
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer.人参皂苷Rg3:转移性乳腺癌中的潜在分子靶点与治疗适应症
Medicines (Basel). 2019 Jan 23;6(1):17. doi: 10.3390/medicines6010017.
10
Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.人参皂苷Rh2通过靶向CNNM1抑制前列腺癌血管生成。
J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404.